Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Alan Horwich(Institute of Cancer Research), Vesa Kataja(Kuopio University Hospital), C. Bangma(Erasmus MC), Chris Parker(Royal Marsden NHS Foundation Trust)
Cited by 600
Related Papers
Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer
|New England Journal of Medicine|2013|3.3k
Adjuvant Docetaxel or Vinorelbine with or without Trastuzumab for Breast Cancer
|New England Journal of Medicine|2006|1.4k
Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial
|Annals of Oncology|2014|1.3k
Multiple newly identified loci associated with prostate cancer susceptibility
|Nature Genetics|2008|850
A recurrent mutation in PALB2 in Finnish cancer families
|Nature|2007|461